Patents Represented by Attorney James L. McGinnus
  • Patent number: 7163932
    Abstract: The invention encompasses the novel class of compounds represented by the formula below, which are inhibitors of the PTP-1B enzyme. The invention also encompasses pharmaceutical compositions which include the compounds shown above and methods of treating or preventing PTP-1B mediated diseases, including diabetes.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: January 16, 2007
    Assignee: Merck Frosst Canada & Co.
    Inventors: Claude Dufresne, Yves Leblanc, Cheuk K. Lau, Patrick Roy, Chun Sing Li